ATE6312T1 - Verfahren zur immunologischen bestimmung von basalmembranmaterial, hierfuer geeignete basalmembranfragmente und verfahren zu deren herstellung, bzw. gewinnung. - Google Patents

Verfahren zur immunologischen bestimmung von basalmembranmaterial, hierfuer geeignete basalmembranfragmente und verfahren zu deren herstellung, bzw. gewinnung.

Info

Publication number
ATE6312T1
ATE6312T1 AT80103095T AT80103095T ATE6312T1 AT E6312 T1 ATE6312 T1 AT E6312T1 AT 80103095 T AT80103095 T AT 80103095T AT 80103095 T AT80103095 T AT 80103095T AT E6312 T1 ATE6312 T1 AT E6312T1
Authority
AT
Austria
Prior art keywords
basal membrane
recovery
production
immunological determination
membrane material
Prior art date
Application number
AT80103095T
Other languages
German (de)
English (en)
Inventor
Rupert Dr. Timpl
Original Assignee
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. filed Critical Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V.
Application granted granted Critical
Publication of ATE6312T1 publication Critical patent/ATE6312T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT80103095T 1979-06-11 1980-06-03 Verfahren zur immunologischen bestimmung von basalmembranmaterial, hierfuer geeignete basalmembranfragmente und verfahren zu deren herstellung, bzw. gewinnung. ATE6312T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792923583 DE2923583A1 (de) 1979-06-11 1979-06-11 Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
EP80103095A EP0021152B1 (de) 1979-06-11 1980-06-03 Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung

Publications (1)

Publication Number Publication Date
ATE6312T1 true ATE6312T1 (de) 1984-03-15

Family

ID=6072965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80103095T ATE6312T1 (de) 1979-06-11 1980-06-03 Verfahren zur immunologischen bestimmung von basalmembranmaterial, hierfuer geeignete basalmembranfragmente und verfahren zu deren herstellung, bzw. gewinnung.

Country Status (5)

Country Link
US (1) US4340581A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0021152B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (4) JPS561353A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE6312T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE2923583A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4565789A (en) * 1983-04-04 1986-01-21 The United States Of America As Represented By The Department Of Health And Human Services Cell matrix receptor system and use in cancer diagnosis and management
US4683135A (en) * 1983-07-27 1987-07-28 Yeda Research And Development Co., Ltd. DSCG binding protein and process for preparing same
DE3331627A1 (de) * 1983-09-01 1985-03-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur immunologischen bestimmung fuer proteine in koerperfluessigkeiten, unter verwendung monovalenter antikoerperfragmente
DE3433021A1 (de) * 1984-09-07 1986-03-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung der globulaeren domaene von basalmembrankollagen und immunologische bestimmung von basalmembranmaterial und autoantikoerpern
EP0155676A3 (de) * 1984-03-19 1988-02-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Gewinnung der globulären Domäne von Basalmembrankollagen und immunologische Bestimmung von Basalmembranmaterial und Autoantikörpern
DE3410049A1 (de) * 1984-03-19 1985-09-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung der globulaeren domaene von basalmembrankollagen und immunologische bestimmung von basalmembranmaterial und autoantikoerpern
US5177020A (en) * 1985-03-28 1993-01-05 Hoechst Aktiengesellschaft Method for the immunological determination of heparan sulfate-proteoglycan and process for the preparation and purification of heparan sulfate-proteoglycan suitable for this purpose from tissues containing basal membrane
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
DE3708198A1 (de) * 1987-03-13 1988-09-22 Hoechst Ag Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
US4870160A (en) * 1987-08-19 1989-09-26 Regents Of The University Of Minnesota Polypeptides with laminin activity
US5211657A (en) * 1988-11-07 1993-05-18 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5264370A (en) * 1988-12-12 1993-11-23 Bainbridge Laboratories, Inc. Detection of basement membrane components as diagnostic of cancer and other diseases
JPH04502363A (ja) * 1988-12-12 1992-04-23 バード　ダイアグノスティック　サイエンシズ，インコーポレイティド 癌及びその他の疾病の診断としての基底膜成分の検出
JPH03108665A (ja) * 1988-12-23 1991-05-08 Nippon Dpc Corp 生物学的液体中の４型コラーゲンペプチドの免疫学的な測定法及び測定キット
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
US5541295A (en) * 1993-02-12 1996-07-30 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Detection of type II collagen and its peptides
US5668824A (en) * 1993-07-28 1997-09-16 Cynosure, Inc. Method and apparatus for replenishing dye solution in a dye laser
AU2002214333A1 (en) * 2000-11-22 2002-06-03 Matsuura, Eiji Method of assaying antilaminin-1 antibody and application thereof
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
US9012160B2 (en) * 2008-06-16 2015-04-21 Abraham Amir Monitoring skin metabolism products for evaluating burn injury
US20130303649A1 (en) 2010-12-02 2013-11-14 Kaneka Corporation Active energy ray-curable composition for optical material, cured product, and production method
KR102342629B1 (ko) 2012-04-18 2021-12-22 싸이노슈어, 엘엘씨 피코초 레이저 장치 및 그를 사용한 표적 조직의 치료 방법
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
CA3150047A1 (en) 2019-08-07 2021-02-11 3M Innovative Properties Company Tape, article including tape and composite layer, and related methods
AU2023205729A1 (en) * 2022-01-04 2024-07-11 Ronawk, Inc. Genetically reprogrammed extracellular matrix

Also Published As

Publication number Publication date
JPH0413359B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-03-09
EP0021152A1 (de) 1981-01-07
EP0021152B1 (de) 1984-02-15
JPH0445520B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-07-27
JPH0122904B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-04-28
JPS561353A (en) 1981-01-09
JPH0415240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-03-17
DE2923583A1 (de) 1980-12-18
US4340581A (en) 1982-07-20
JPH0257194A (ja) 1990-02-26
JPH02199A (ja) 1990-01-05
JPH0256500A (ja) 1990-02-26
DE3066566D1 (en) 1984-03-22

Similar Documents

Publication Publication Date Title
ATE6312T1 (de) Verfahren zur immunologischen bestimmung von basalmembranmaterial, hierfuer geeignete basalmembranfragmente und verfahren zu deren herstellung, bzw. gewinnung.
AT374471B (de) Verfahren zur herstellung von neuen 2pyridylalkyl-sulfinyl-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
GB2027614B (en) Semipermeable composite membrane and process for preparation thereof
ATE65716T1 (de) Struktur mit membranen, die durchgehende poren aufweisen, verfahren zum herstellen dieser struktur sowie verwendungen der struktur.
AT374477B (de) Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
ATE4952T1 (de) Wiederverwendbare, schlauchfoermige umhuellung sowie apparat mit dieser umhuellung und verfahren zur herstellung von wurstwaren ohne umhuellung, insbesondere fuer gekochte oder rohe wurstwaren.
DE3587268D1 (de) Verfahren zur isolierung des mycobakteriellen antigens-a60 und die verwendung dieses antigens zur herstellung von immunologischen reagenzien und in immunologischen testverfahren.
AT387959B (de) Verfahren zur herstellung von tert. butylalkylaethern in gegenwart von butadien
ATA208987A (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
AT382553B (de) Verfahren zur herstellung von behaeltern durch tiefziehen und durch dieses verfahren hergestellter behaelter
ATE3866T1 (de) Verfahren zur herstellung einer kollagenloesung, eine solche loesung sowie ihre verwendung.
ATA334780A (de) Verfahren zur herstellung von neuen peptidamiden
ATE5592T1 (de) Verfahren zur herstellung von 4'deoxydaunorubicin und 4'-deoxydoxorubicin, sowie 4'-epi-4'-trifluormethyl-sulfonyloxy-ntrifluoracetyldaunorubicin.
DE3880583D1 (de) Polyurethan-emulsion, deren verwendung zur herstellung von bahnmaterialien sowie herstellungsverfahren dieser materialien.
AT367734B (de) Verfahren zur herstellung neuer tert. 3-aminoaethylphenole und ihrer salze
ATE29137T1 (de) Verfahren zur herstellung zell- und geweberegenerierender stoffe.
DE3768720D1 (de) Verfahren zur trennung von aminosaeuren.
ATA655279A (de) Verfahren zur herstellung von neuen isocyanyros[urederivaten
DE3851462D1 (de) Verfahren zur Herstellung eines supraleitenden Materials des Oxydverbundtyps.
DE59004588D1 (de) Verfahren zur Herstellung von Purpurmembran enthaltend Bacteriorhodopsin.
ATA367580A (de) Verfahren zur herstellung von biologisch vertraeglichen materialien
ATA345079A (de) Verfahren zur herstellung von 4'-substituierten 2,4-dichlor-alpha-(imidazol-n-ylmethyl)dibenzyl[thern und von deren salzen
AT371465B (de) Verfahren zur herstellung von neuen 2-azaergolinen und 2-aza-8(oder 9)-ergolenen
AT382554B (de) Verfahren zur herstellung von behaeltern durch tiefziehen und durch dieses verfahren hergestellter behaelter
AT386225B (de) Verfahren zur hestellung von 17-c-steroid-alpha- propionsaeureverbindungen, insbesondere von 3-oxopregna-4-en-20-carbons|ure und/oder 3-oxo-pregna-1,4-dien-20-carbonsaeure

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time